Sort
21,281 grants matching “influenza”
Core for COVID-19 Cohort IMPACC
$954,979David A. Hafler · Yale University · U19 · FY2021 · AI
Implications of long germinal centers (GC) for T and B cell memory and mucosal immunity
$954,951Shane P Crotty · La Jolla Institute For Immunology · U19 · FY2025 · AI
Enhanced Surveillance for New Vaccine Preventable Diseases
$954,794Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2008 · IP
Innate Control of SIV-Specific Adaptive Immunity
$954,337Bali Pulendran · Emory University · U19 · FY2015 · AI
Disease Modeling of Influenza and Other Emerging Respiratory Viral Pathogens
$953,984Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
CAP: Trivalent Filovirus Vaccine for Pre- and Post-Exposure Vaccination
$953,984Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Adenovirus Protease Regulation and Antiviral Development
$953,757Brookhaven Science Assoc-Brookhaven Lab · R01 · FY2003 · AI
7HP349, an oral integrin activator to augment effectiveness of pre-exposure influenza vaccination
$953,477Upendra Marathi · 7 Hills Pharma, Llc · R44 · FY2024 · AI
Core 1: Facility Management, Maintenance and Operations Core
$953,343Colin S. Duckett · Duke University · UC7 · FY2024 · AI
Enhanced Oral Vaccine Delivery Vehicle
$953,135Sean N Tucker · Vaxart, Inc. · R44 · FY2009 · AI
5 YEAR STRATEGY FOR REDUCING MORBIDITY & MORTALITY CAUSED BY INFLUENZA
$952,927Caroline Brown · World Health Organization · U51 · FY2014 · IP
FROM GENOMIC SEQUENCES TO PROTEIN STRUCTURE/FUNCTION
$952,507University Of Md Biotechnology Institute · P01 · FY2001 · GM
Microneedle Delivery of Zanamivir for Treatment of Influenza
$952,176Elke Lipka · Tsrl, Inc. · R44 · FY2021 · AI
Targeting the NS1 Protein for the Development of Influenza Virus Antivirals
$951,603Robert M Krug · University Of Texas At Austin · U01 · FY2008 · AI
Does repeated influenza vaccination constrain influenza immune responses and protection?
$951,396Sheena G Sullivan · University Of Melbourne · R01 · FY2021 · AI
Advanced testing of a hexavalent adjuvanted influenza vaccine platform for dose sparing, multiplexing, and rapid deployment
$950,225Hilliard Kutscher · Pop Biotechnologies, Inc · R44 · FY2024 · AI
Delphi Influenza Forecasting Center of Excellence
$950,000Ronald Rosenfeld · Carnegie-Mellon University · U01 · FY2023 · IP
Delphi Influenza Forecasting Center of Excellence
$950,000Ronald Rosenfeld · Carnegie-Mellon University · U01 · FY2021 · IP
DEVELOPMENT OF INFLUENZA SURVEILLANCE NETWORKS
$950,000Pathom Sawanpanyaler · Thailand Ministry Of Public Health · U50 · FY2006 · CI
Influenza Forecasting Center of Excellence at University of Massachusetts Amherst
$950,000Nicholas G Reich · University Of Massachusetts Amherst · U01 · FY2022 · IP
Delphi Influenza Forecasting Center of Excellence
$950,000Ronald Rosenfeld · Carnegie-Mellon University · U01 · FY2022 · IP
Influenza Forecasting Center of Excellence at University of Massachusetts Amherst
$950,000Nicholas G Reich · University Of Massachusetts Amherst · U01 · FY2023 · IP
Development of Aersolized Vaccines
$949,976Mario Roederer · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Influenza Forecasting Center of Excellence at University of Massachusetts Amherst
$949,974Nicholas G Reich · University Of Massachusetts Amherst · U01 · FY2021 · IP
Clinical and Statistical
$949,444Mark Joseph Mulligan · Emory University · U19 · FY2013 · AI